Pallas Capital Advisors »

Humacyte shares owned by Pallas Capital Advisors

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Pallas Capital Advisors from 13F filings

Historical chart of Pallas Capital Advisors investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Pallas Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Pallas Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $13k 22k 0.61
2025-06-30 $42k 20k 2.09

More positions owned by Pallas Capital Advisors

Bruker Corporation (BRKR)
Global Partners Com Units (GLP)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Intl (FNDF)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Dimensional Etf Trust Internatnal Val (DFIV)
Fidelity Covington Trust Enhanced Intl (FENI)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Broadcom (AVGO)

View all positions for Pallas Capital Advisors

Top funds holding Humacyte

BlackRock
Vanguard Group
Vanguard Capital Management
Antipodes Partners
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
State Street Corporation
UBS Group
Woodline Partners
AQR Capital Management
Susquehanna International
Vanguard Portfolio Management
Charles Schwab Investment Management
Northern Trust
Vanguard Fiduciary Trust

View all funds holding Humacyte